Prospective, Observational Registry of Renaissance-guided Spine Surgeries

计划入组 93 人 · 首次发布于 2014 年 8 月 8 日

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

计划入组 200 人 · 首次发布于 2023 年 12 月 28 日

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

计划入组 216 人 · 首次发布于 2025 年 1 月 29 日

nanoRNA therapeutic (Lakewood)

nanoRNA therapeutic (Lakewood-Amedex)

Epstein Barr virus nRNA (Lakewood Amedex)

Renaissance Lakewood LLC

United States

Renaissance Lakewood, LLC

United States

Lakewood-Amedex Inc.

United States

LTS Acquires Renaissance Lakewood to Expand CDMO Capabilities in Nasal Drug Delivery

ARS Pharma's Neffy Aims to Expand Pediatric Access for Type 1 Allergic Reactions

Psychedelics in Medicine: A Renaissance in Mental Health Treatment